"Diterpenes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Twenty-carbon compounds derived from MEVALONIC ACID or deoxyxylulose phosphate.
| Descriptor ID |
D004224
|
| MeSH Number(s) |
D02.455.849.291
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Diterpenes".
Below are MeSH descriptors whose meaning is more specific than "Diterpenes".
This graph shows the total number of publications written about "Diterpenes" by people in this website by year, and whether "Diterpenes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diterpenes" by people in Profiles.
-
Starks CM, Norman VL, Williams RB, Goering MG, Rice SM, O'Neil-Johnson M, Eldridge GR. Antibacterial activity of Taxodium ascendens diterpenes against methicillin-resistant Staphylococcus aureus. Nat Prod Commun. 2014 Aug; 9(8):1129-30.
-
Starks CM, Williams RB, Goering MG, O'Neil-Johnson M, Norman VL, Hu JF, Garo E, Hough GW, Rice SM, Eldridge GR. Antibacterial clerodane diterpenes from Goldenrod (Solidago virgaurea). Phytochemistry. 2010 Jan; 71(1):104-9.
-
Parish LC, Parish JL. Retapamulin: a new topical antibiotic for the treatment of uncomplicated skin infections. Drugs Today (Barc). 2008 Feb; 44(2):91-102.
-
Parish LC, Jorizzo JL, Breton JJ, Hirman JW, Scangarella NE, Shawar RM, White SM. Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial. J Am Acad Dermatol. 2006 Dec; 55(6):1003-13.
-
Pi F, Hotter G, Closa D, Rosell?-Catafau J, Bulbena O, Badosa F, Morris M, Fern?ndez-Cruz L, Gelpi E. Effect of a platelet-activating factor antagonist and desferrioxamine administration on eicosanoid production in rat pancreas transplantation. Transplantation. 1994 Jan; 57(1):12-7.
-
Klein-Szanto AJ, Major SK, Slaga TJ. Quantitative evaluation of dark keratinocytes induced by several promoting and hyperplasiogenic agents: their use as an early morphological indicator of tumor-promoting action. Carcinog Compr Surv. 1982; 7:305-9.
-
Slaga TJ, Fischer SM, Weeks CE, Nelson K, Mamrack M, Klein-Szanto AJ. Specificity and mechanism(s) of promoter inhibitors in multistage promotion. Carcinog Compr Surv. 1982; 7:19-34.
-
Marchok AC, Clark JN, Klein-Szanto A. Modulation of growth, differentiation, and mucous glycoprotein synthesis by retinyl acetate in cloned carcinoma cell lines. J Natl Cancer Inst. 1981 Jun; 66(6):1165-74.
-
Klein-Szanto AJ, Major SK, Slaga TJ. Induction of dark keratinocytes by 12-O-tetradecanoylphorbol-13-acetate and mezerein as an indicator of tumor-promoting efficiency. Carcinogenesis. 1980 May; 1(5):399-406.
-
Slaga TJ, Klein-Szanto AJ, Fischer SM, Weeks CE, Nelson K, Major S. Studies on mechanism of action of anti-tumor-promoting agents: their specificity in two-stage promotion. Proc Natl Acad Sci U S A. 1980 Apr; 77(4):2251-4.